Importance of cryptolytic lesions and pericryptal granulomas in inflammatory bowel disease.
Correspondence
Defining epithelioid cell granulomas A journal of evidence-based health care recently featured an editorial' emphasising interobserver disagreement between pathologists and ipso facto the unreliability of histopathology as the "gold standard diagnosis". Recent initiatives to clarify evidencebased histopathology and reduce interobserver disagreement are therefore welcomed. A recent case of clinical chronic ulcerative colitis in which sequential biopsies showed frequent pericryptal aggregates of epithelioid histiocytes caused us to consult both the guidelines for the initial biopsy diagnosis of chronic idiopathic inflammatory bowel disease (CIBD)5 and a simultaneous publication by Lee et al3 addressing the topic of the diagnosis and significance of intramucosal granulomas in CIBD. We were immediately struck by the disparity between the text definitions of epithelioid cell granulomas and the photomicrographs in both articles. Both defined these as discrete collections of at least five epithelioid cells with or without accompanying giant cells; however, in practice these are extremely difficult to count as cytoplasmic boundaries are invariably indistinct Importance of cryptolytic lesions and pericryptal granulomas in inflammatory bowel disease Professor Lee and colleagues' have addressed the significance of a granulomatous reaction to disrupted inflamed colorectal crypts in an important and meticulous study. This is a confusing area of colorectal pathology that has been neglected and Lee et al's approach of separating true cryptolytic epithelioid cell granulomas from focal pericryptal chronic inflammation without epithelioid histiocytes (including "mucin granulomas") represents a major contribution to the biopsy diagnosis of inflammatory bowel disease.
While Lee et al's findings indicate that segmental crypt disruption by proper epithelioid granulomatous inflammation is a much more specific marker of Crohn's disease than other forms of focal cryptitis, they demonstrate that there are nevertheless occasional instances when even this feature occurs in patients with probable ulcerative colitis, or indeed with no chronic inflammatory bowel disease at all, after full clinicopathological correlation. They also refer to published descriptions of pericryptal granulomas in infective colitis and diverticular colitis. We have had similar experiences of cryptolytic epithelioid granulomas in all of these situations as well as in pouchitis' and diversion colitis.3 We have also observed the lesion, with an accompanying mild "colitis", misdiagnosed as Crohn's disease on an initial biopsy, when the ultimate diagnosis was secondary inflammatory changes immediately adjacent to a colonic adenocarcinoma.
We certainly agree with Lee et al that the finding of cryptolytic epithelioid granulomas should always raise the suspicion of Crohn's disease, sufficient to warrant further investigation, but we wish to reinforce caution that the diagnosis must not be made on this feature alone. We are particularly concerned about the implications of finding cryptolytic granulomas on the decision whether to undertake future pelvic ileal reservoir surgery and we are uneasy about the last sentence of Lee et alrs paper ". . the presence of pericryptal granulomas should signal a warning to surgeons that ileoanal pouch construction might have unwelcome consequences". We have observed a number of patients with such lesions in mucosal biopsies or in colectomy specimens who have proceeded to successful pelvic ileal reservoir surgery when careful preoperative review of the whole clinicopathological picture has identified no other suggestion of Crohn's disease. We therefore consider that pericryptal granulomas alone cannot be sufficient reason to deny a patient the benefit of a successful restorative operation when it is otherwise appropriate. Professor Lee et al comment: I was most interested to read the comments made by Warren and his distinguished colleagues regarding our article on cryptolytic lesions and pericryptal granulomas in colorectal biopsies. We are of course well aware of the conventional view of such lesions, which many consider to be too widespread to have any serious diagnostic significance. We are also interested to hear that patients whose biopsies showed pericryptal granulomas have proceeded to ileoanal pouch construction without further incident. Other patients may not however have been quite so fortunate as is illustrated by the following case, which also addresses many of the issues raised by Warren and colleagues. The patient in question, a 28 year old man, experienced rupture of an ileoanal pouch 14 months after pouch construction that was done following a diagnosis of severe ulcerative colitis. Review of the histological sections from the previous colectomy specimen revealed numerous pericryptal granulomas, which had been attributed to crypt rupture and discounted because the generality of the histological changes favoured a diagnosis of ulcerative colitis. Histological examination of the ruptured pouch also revealed numerous Correspondence, Book reviews, Notices pericryptal granulomas. There are thus reasonable grounds for supposing that this patient had been suffering from Crohn's disease from the outset. In this case at least a warning to the surgeons that ileoanal pouch construction might have unwelcome consequences would have been entirely justified.
The received wisdom is that the presence of a pericryptal granuloma regardless of the context in which it arises is a diagnostic pitfall; but perhaps as the above case illustrates, the pitfall may be the other way round.
Colorectal cancer reporting The article by Shepherd and Quirke' is timely and publication coincided with the completion of our own colorectal cancer reporting sheet (fig 1) . This was designed for in-house use to supplement a laboratory protocol for handling and reporting colorectal malignancy resection specimens and to improve the accuracy and consistency of reporting. The top part of the sheet is filled in by the surgeon in the operating theatre and the specimens are handled according to ACP guidelines.2 Together with the separate free text histology report, the sheet will be filed in the patient's clinical case notes and will be the source of the histopathological data that will be used, eventually, in the multidisciplinary database that we hope to have available for colorectal cancer patients in this unit.
The general layout of our form owes much to the "Sloane" forms for the reporting of breast screening histopathology and we are pleased to see that Professor Sloane is to chair the forthcoming Royal College of Pathologists' working party. However, unlike breast screening, reduction of mortality and morbidity from colorectal cancer is not a Health of the Nation target. For colorectal cancer this cancer unit is going to need at least one clerk to help gather and correlate data from several different sources including outpatients, radiology, operating theatres, histopathology, and oncology. The clinical audit committee at the Peterborough Hospitals NHS Trust has decided that cancer database entry is not an appropriate use of clinical audit facilitator time or audit funds. The decision was based on the fact that the clinical audit department is unlikely to be able to cope with the vast amount of data that will need to be collected for multiple cancers 
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